JAKAVI (ruxolitinib) for the treatment of myelofibrosis and for the treatment of polycythaemia vera in patients resistant to or intolerant of hydroxyurea.
Domain | jakavi.com |
---|---|
Homepage URL | http://www.jakavi.com |
Keywords | jakavi ruxolitinib myelofibrosis polycythaemia vera polycythemia mf pv mpn treatment for jak inhibitor inhibition myeloproliferative neoplasm |
Sprache | englisch |